AA amyloidosis
AA amyloidosis
Explore linked clinical trials. Standard reference: MONDO:00194392 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma | AA amyloidosis, Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell myeloma, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 2 | 2026-08-05 | NCT03346135 | |
| Unclassified GENotypes of Autoinflammatory Diseases and AA Amyloidosis | AA amyloidosis | Recruiting | Not stated | 2025-09-02 | NCT06354322 |